Literature DB >> 32413549

Hemodynamic Collapse After Influenza Vaccination: A Vaccine-Induced Fulminant Myocarditis?

Nobutaka Nagano1, Toshiyuki Yano2, Yugo Fujita1, Masayuki Koyama3, Ryo Hasegawa1, Jun Nakata1, Ryo Nishikawa1, Naoto Murakami1, Takefumi Fujito1, Atsushi Mochizuki1, Hidemichi Kouzu1, Atsuko Muranaka1, Nobuaki Kokubu1, Tetsuji Miura1.   

Abstract

A 14-year-old girl with cardiopulmonary arrest was referred to our hospital. She had received an injection of inactivated influenza vaccine 7 days before the referral. Her cardiac rhythm was pulseless wide QRS tachycardia, and mechanical circulatory support was immediately begun. Results of endomyocardial biopsy showed that there was massive infiltration of CD3- and CD68-positive cells and various degrees of cardiomyocyte necrosis in all of 3 endomyocardial specimens, whereas infiltration of eosinophils or giant cells was not observed. A histologic diagnosis of lymphocytic myocarditis was made. Acute myocarditis is a rare but potentially fatal complication of the influenza vaccination.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32413549     DOI: 10.1016/j.cjca.2020.05.005

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support.

Authors:  Mitsukuni Kimura; Toru Hashimoto; Eri Noda; Yusuke Ishikawa; Akihito Ishikita; Takeo Fujino; Shouji Matsushima; Tomomi Ide; Shintaro Kinugawa; Kazuhiro Nagaoka; Tomoki Ushijima; Akira Shiose; Hiroyuki Tsutsui
Journal:  ESC Heart Fail       Date:  2022-05-26

Review 2.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report.

Authors:  Arianne Clare C Agdamag; Daniel Gonzalez; Katie Carlson; Suma Konety; William C McDonald; Cindy M Martin; Valmiki Maharaj; Tamas Alexy
Journal:  Eur Heart J Case Rep       Date:  2022-01-10

Review 4.  COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.

Authors:  Sadeer Al-Kindi; David A Zidar
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

Review 5.  Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).

Authors:  Audry S Y Lee; Iswaree D D/O Balakrishnan; Chun Yuan Khoo; Choon Ta Ng; Julian K X Loh; Laura L Chan; Louis L Y Teo; David K L Sim
Journal:  Heart Lung Circ       Date:  2022-02-25       Impact factor: 2.838

6.  Acute Lymphocyte Myocarditis Associated with Influenza Vaccination.

Authors:  Ryo Nakamura; Shin-Ichi Ando; Seiya Kato; Toshiaki Kadokami
Journal:  Intern Med       Date:  2022-01-13       Impact factor: 1.282

Review 7.  Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.

Authors:  Bettina Heidecker; Noa Dagan; Ran Balicer; Urs Eriksson; Giuseppe Rosano; Andrew Coats; Carsten Tschöpe; Sebastian Kelle; Gregory A Poland; Andrea Frustaci; Karin Klingel; Pilar Martin; Joshua M Hare; Leslie T Cooper; Antonis Pantazis; Massimo Imazio; Sanjay Prasad; Thomas F Lüscher
Journal:  Eur J Heart Fail       Date:  2022-09-06       Impact factor: 17.349

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.